First-ever gene edit of infant boy leads to apparent curenews2025-01-08T20:57:25+00:00January 8th, 2025|Endpoints News|
Pfizer, GSK add risk of Guillain-Barré to RSV vaccine labelsnews2025-01-08T18:46:16+00:00January 8th, 2025|Endpoints News|
Astellas stops developing autologous cell therapy for lymphomanews2025-01-08T18:14:37+00:00January 8th, 2025|Endpoints News|
Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapiesnews2025-01-08T13:00:24+00:00January 8th, 2025|Endpoints News|
Vir’s early T cell engager data offer first look at cancer pivot, stock jumpsnews2025-01-08T12:45:28+00:00January 8th, 2025|Endpoints News|
Updated: Galapagos to split into two companies, slash headcount as it eyes turnaroundnews2025-01-08T12:22:01+00:00January 8th, 2025|Endpoints News|
LB Pharmaceuticals reveals Phase 2 schizophrenia datanews2025-01-08T12:00:53+00:00January 8th, 2025|Endpoints News|
Jasper reports more data in spontaneous hives from tiny studynews2025-01-08T12:00:43+00:00January 8th, 2025|Endpoints News|
Calico, Denali’s ALS drugs miss primary objectives in basket studynews2025-01-07T16:30:33+00:00January 7th, 2025|Endpoints News|
Immuneering touts positive pancreatic cancer data for MEK inhibitornews2025-01-07T16:13:43+00:00January 7th, 2025|Endpoints News|
